Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Methotrexate | 0.01 | uM | 4 | 625.00 | 288.04 | 851.00 | 740.75 | 1.1488 | 1.2144 |
| BT-20 | Omipalisib | 1 | uM | 4 | 625.00 | 288.04 | 181.00 | 740.75 | 0.2444 | -0.2889 |
| BT-20 | Methotrexate | 10 | uM | 4 | 625.00 | 288.04 | 954.00 | 740.75 | 1.2879 | 1.4080 |
| BT-20 | Palbociclib | 1 | uM | 4 | 625.00 | 288.04 | 294.00 | 740.75 | 0.3969 | 0.0151 |
| BT-20 | Methotrexate | 0.31623 | uM | 4 | 625.00 | 288.04 | 721.00 | 740.75 | 0.9733 | 0.9607 |
| BT-20 | Taxol | 0.0031623 | uM | 4 | 625.00 | 288.04 | 653.00 | 740.75 | 0.8815 | 0.8233 |
| BT-20 | Methotrexate | 0.1 | uM | 4 | 625.00 | 288.04 | 1014.00 | 740.75 | 1.3689 | 1.5183 |
| BT-20 | Omipalisib | 0.31623 | uM | 4 | 625.00 | 288.04 | 182.00 | 740.75 | 0.2457 | -0.2860 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 963.00 | 740.75 | 1.3000 | 1.4247 | |
| BT-20 | Palbociclib | 0.31623 | uM | 4 | 625.00 | 288.04 | 405.00 | 740.75 | 0.5467 | 0.2841 |
| BT-20 | Omipalisib | 0.01 | uM | 4 | 625.00 | 288.04 | 409.00 | 740.75 | 0.5521 | 0.2934 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 808.00 | 740.75 | 1.0908 | 1.1317 | |
| BT-20 | Omipalisib | 0.0033113 | uM | 4 | 625.00 | 288.04 | 918.00 | 740.75 | 1.2393 | 1.3410 |
| BT-20 | Taxol | 0.1 | uM | 4 | 625.00 | 288.04 | 220.00 | 740.75 | 0.2970 | -0.1794 |
| BT-20 | Taxol | 0.001 | uM | 4 | 625.00 | 288.04 | 699.00 | 740.75 | 0.9436 | 0.9166 |
| BT-20 | Palbociclib | 3.1623 | uM | 4 | 625.00 | 288.04 | 404.00 | 740.75 | 0.5454 | 0.2818 |
| BT-20 | Palbociclib | 0.031623 | uM | 4 | 625.00 | 288.04 | 358.00 | 740.75 | 0.4833 | 0.1730 |
| BT-20 | Palbociclib | 19.9526 | uM | 4 | 625.00 | 288.04 | 335.00 | 740.75 | 0.4522 | 0.1172 |
| BT-20 | Omipalisib | 10 | uM | 4 | 625.00 | 288.04 | 79.00 | 740.75 | 0.1067 | -0.6130 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 745.00 | 740.75 | 1.0057 | 1.0084 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 554.00 | 740.75 | 0.7479 | 0.6160 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1512.00 | 1986.88 | 0.7610 | 0.6822 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1799.00 | 1986.88 | 0.9054 | 0.8780 | |
| BT-20 | Methotrexate | 0.0016596 | uM | 4 | 1250.00 | 665.42 | 1797.00 | 1986.88 | 0.9044 | 0.8767 |
| BT-20 | Methotrexate | 0.0033113 | uM | 4 | 1250.00 | 665.42 | 2084.00 | 1986.88 | 1.0489 | 1.0614 |